SCHEMBL1827333

SCHEMBL1827333

Cc1ccc(S(=O)(=O)Oc2cccc(C(C#N)OCc3ccccc3)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SGMS2 Q8NHU3 1/20 0.40
ALDH1A1 P00352 4/20 0.40
LMNA P02545 2/20 0.39
HPGD P15428 2/20 0.39
AR P10275 1/20 0.38
GPR17 Q13304 2/20 0.38
P2RY2 P41231 1/20 0.38
KDM4E B2RXH2 1/20 0.38
RECQL P46063 1/20 0.38
MAOB P27338 1/20 0.38
MAPT P10636 3/20 0.38
GAA P10253 1/20 0.38
G6PD P11413 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
DRD2 P14416 1/20 0.38
DRD1 P21728 1/20 0.38
DRD4 P21917 1/20 0.38
DRD5 P21918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1823249 0.92 SGMS2 (0.44) KMT2ASGMS2ALDH1A1LMNAHPGD
SCHEMBL1826444 0.88 ALDH1A1 (0.44) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL1827190 0.85 MEN1 (0.43) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL1824278 0.84 ALDH1A1 (0.44) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL1828852 0.84 SGMS2 (0.44) KMT2ASGMS2ALDH1A1MAOBCTSL
SCHEMBL1823596 0.82 KMT2A (0.42) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL1825564 0.81 ALDH1A1 (0.43) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL1827095 0.81 P2RX7 (0.43) MEN1KMT2ALMNAARGPR17
SCHEMBL1825646 0.80 GPR17 (0.44) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL1825822 0.79 TDP1 (0.47) ALDH1A1ARMAOBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 MEN1 421/4885KMT2A 1068/4885SGMS2 3116/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 MEN1 183/4885KMT2A 1084/4885SGMS2 2464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.